Work with Dr Toussi

Training, Speaking
& Advisory

Evidence Mastery offers four distinct modes of engagement — focused on education, knowledge transfer, and scientific leadership. No direct consulting. No competing interests.

🏫 Corporate Training 🎤 Keynote Speaking 🔬 Scientific Advisory 🏢 Board Membership
Dr Massoud Toussi
Currently
Vice President, Real-World Evidence — UBC
MDMedical doctor — general medicine, with a degree in psychiatry
PhDMedical informatics & healthcare data analysis — Universities of Paris VI and XIII
MBAUniversité Paris Dauphine
MScInternational management — Université du Québec à Montréal (UQAM)
Who you’ll work with

Massoud Toussi,
MD, PhD, MBA

A physician–scientist and pharmacoepidemiologist with more than 20 years across pharmaceutical companies, CROs, regulatory agencies, academia and patient organisations.

Today Vice President of Real-World Evidence at UBC, previously Vice President and Global Head of RWE at Cytel, and before that in senior global roles at IQVIA, where he led the post-authorisation safety and effectiveness study offering (PASS, PAES, REMS, DUS). He has designed, led or overseen hundreds of studies across every major therapeutic area and five continents.

🩺
Clinical, data & business lens
Trained as a physician, a health-data scientist and a manager — fluent with clinicians, statisticians and executives alike.
🌎
Execution at global scale
Hundreds of multinational observational studies, from protocol to regulatory submission, for sponsors large and small.
⚖️
Standards & policy insight
Contributor to scientific standards through ENCePP, ISPE, ISPOR, HTAi and EU2P, including co-leading HTAi interest-group work on RWE and AI.
🎓
Teaching that translates
Author of the five-volume Evidence Mastery series and 50+ peer-reviewed publications; teaches in English and French.
UBCCytelIQVIA HTAiISPORISPE ENCePPEU2P
👤 LinkedIn Profile ✉ Get in touch
Services

Four Ways to Engage

🏫
Corporate Training Programmes

Bespoke, expert-led training designed for pharma, biotech, CRO, regulatory, and HTA teams. Delivered in-person or online, customised to your team's level and focus area.

Introduction to Real-World Evidence for non-specialists
RWE study design and methodology workshops
Causal inference and target trial emulation
Regulatory RWE — FDA, EMA, HTA requirements
RWD sources, governance, and fitness-for-purpose
Evidence strategy planning across the product lifecycle
AI and machine learning in RWE
Programmes are designed for teams of 5–50. Duration ranges from a half-day intensive to a multi-session curriculum. Available in English and French.
Enquire About Training →
🎤
Keynote Speaking

Engaging, evidence-based keynotes and expert presentations for conferences, symposia, webinars, and corporate events — on the science and strategy of Real-World Evidence.

The future of Real-World Evidence in regulatory science
RWE in the era of AI — opportunities and pitfalls
From data to decisions — the RWE value chain
Causal inference for the non-methodologist
Building a global RWE programme from scratch
The RWE ecosystem — stakeholders and incentives
Customised topics on request
Available for in-person and virtual events. Keynotes are typically 30–60 minutes with Q&A. Panel moderation and discussant roles also available.
Enquire About Speaking →
🔬
Scientific Advisory Boards

Independent scientific expertise for academic, industry, and non-profit organisations requiring a senior RWE methodologist on their advisory structure.

Protocol review and methodological oversight
RWE methodology advisory for study teams
Scientific advisory board membership (SAB)
Data monitoring committee (DMC) participation
Grant and proposal scientific review
Journal editorial board positions
Advisory engagements are subject to conflict of interest review. All roles are fully transparent and compatible with current primary employment.
Enquire About Advisory →
🏢
Board of Directors & Governance Roles

Strategic governance expertise for organisations in the real-world evidence, digital health, and health data space — bringing scientific depth and industry perspective to the boardroom.

Non-executive director roles (healthcare, health-tech, RWE)
Independent board member positions
Scientific and innovation committee chairs
Strategic advisory to healthcare technology companies
Expert advisory to regulators and HTA bodies
Board engagements are considered on a case-by-case basis, subject to conflict of interest assessment and alignment with primary employment commitments.
Enquire About Board Roles →
"I don't consult — I educate, advise, and build tools. The goal is to raise the standard of Real-World Evidence globally, not to replace the teams doing the work."
— Massoud Toussi, MD, PhD, MBA
How It Works

Engaging with Evidence Mastery

All engagements begin with a brief conversation to confirm alignment, scope, and compatibility with existing commitments.

1
Initial Contact
Send a brief description of your need through the contact form, specifying the type of engagement.
2
Scoping Call
A 30-minute call to discuss your requirements, timeline, and compatibility with current commitments.
3
Proposal
A written outline of the engagement scope, format, and terms — clear and concise.
4
Delivery
The engagement is delivered to the agreed specification, with follow-up as appropriate.
✉ Start the Conversation